Stockreport

Seneca Biopharma Announces Exercise of Warrants for $7.55 Million Gross Proceeds Priced At-the-Market

Seneca Biopharma, Inc.  (SNCA) 
PDF GERMANTOWN, Md., Jan. 17, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various d [Read more]